Article
Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinoma.
Cancer communications - 1 Jan 1990
Andrews P A, Jones J A, Varki N M, Howell S B
Abstract excerpt
We have characterized the acquisition of resistance to cisplatin (DDP) in an in vivo solid tumor model. Human ovarian carcinoma cells (2008 cell line) were grown s.c. as xenografts in athymic mice. Tumors were selected with 3.0 mg/kg of DDP i.p. given once per week for four weeks. One week after the last dose of DDP, cell lines were generated from the tumors. Cells from these lines were then re-inoculated into...
Topics
- Animals
- Cell Line
- Cisplatin
- Dose-Response Relationship, Drug
- Drug Resistance
- Female
- Glutathione
- Humans
- Isoenzymes
- L-Lactate Dehydrogenase
- Metallothionein
